Passed in 1994, the Dietary Supplement Health & Education Act (DSHEA) established a strong, comprehensive regulatory framework for dietary supplements where none existed before. Nearly 30 years later, DSHEA should protect the 21st century consumer who has access to an ever-expanding dietary supplement marketplace. A modernized regulatory structure will protect public health and reinforce the credibility of the dietary supplement category, allowing it to play a more influential role in the healthcare system.
As consumers take control of their healthcare routines, more people are turning to dietary supplements to provide a boost to their wellbeing. Modernized regulations are needed to meet growing consumer demand, strengthen confidence in dietary supplements, and keep pace with the growth of the industry.
It’s a common misconception that the dietary supplements category is not regulated, when in fact it is regulated by multiple government agencies, with manufacturers and retailers also managing responsibility throughout the process.
The dietary supplements segment has just experienced its largest annual growth rate since 1997. Hear from Dr. Pieter Cohen as he shares his insights on how modernization of DSHEA will help improve category compliance and credibility.
CHPA released the following statement in response to new research published in Clinical Toxicology. The study found nine illegal stimulants, including deterenol, in fraudulently marketed sports and weight loss supplements.
For its annual year-in-review series, Chain Drug Review featured CHPA's President & CEO, Scott Melville, who offered industry insights from last year and thoughts on the outlook for 2021.
CHPA released the following statement in response to FDA’s warning that consumers avoid certain male enhancement and weight loss products sold by major online retailers due to hidden, potentially dangerous drug ingredients.
Today’s column in the Los Angeles Times is aligned with calls from responsible manufacturers in the dietary supplement industry who agree that regulations need to be modernized and strengthened.
CHPA submitted comments this week to the Food and Drug Administration regarding the proposed development of an authorized list of dietary ingredients marketed prior to the Dietary Supplement Health and Education Act.
Here CHPA provides feedback on FDA's proposed development of an authorized list of pre-Dietary Supplement Health and Education Act (DSHEA) dietary ingredients.
Scientific experts familiar with herbal products and their testing methods maintain that the DNA barcode test is not an appropriate method to determine what is in an herbal dietary supplement.
Echoing earlier comments submitted to the agency, CHPA and its member companies marketing dietary supplement products support the presumption of safety for dietary ingredients outlined in the 1994 passage of DSHEA.
The industry favors and supports the development of reasonable guidance. However, the agency’s attempt to redefine the NDI notification process contradicts the letter and spirit of DSHEA. The Draft Guidance would undo nearly two decades of agency practice and policy.
